Computational science

Argonne and RIKEN Sign a Memorandum of Understanding in Support of AI for Science

Retrieved on: 
Monday, April 15, 2024

Leaders in high performance computing in the U.S. and Japan have signed a memorandum of understanding (MOU) establishing a cooperative relationship in support of artificial intelligence (AI) computing projects.

Key Points: 
  • Leaders in high performance computing in the U.S. and Japan have signed a memorandum of understanding (MOU) establishing a cooperative relationship in support of artificial intelligence (AI) computing projects.
  • The MOU was signed during a virtual event by Paul Kearns, laboratory director of the U.S. Department of Energy’s Argonne National Laboratory, and RIKEN President Makoto Gonokami of Japan.
  • The MOU identifies areas of mutual interest at Argonne and RIKEN, Japan’s flagship research institute devoted to basic and applied research.
  • The two institutions agreed to develop and evaluate new computing system software and science and engineering applications, including generative AI models, computing system operations, data management, AI architecture and remote methodologies.

Affinia Therapeutics to Present Data on Novel Cardiotropic and BBB-Penetrant AAV Capsids and Preclinical Efficacy and Safety in Genetic Cardiomyopathies and Sporadic ALS at the American Society of Gene & Cell Therapy 2024 Annual Meeting

Retrieved on: 
Monday, April 22, 2024

Affinia's novel capsids have favorable manufacturing yields and levels of preexisting population immunity.

Key Points: 
  • Affinia's novel capsids have favorable manufacturing yields and levels of preexisting population immunity.
  • "We are excited to unveil data on our next-generation bespoke capsids that demonstrate robust cardiac transduction while detargeting the liver and DRG.
  • One oral presentation showcases data from Affinia's novel, BBB-penetrant AAV capsid with a potential therapeutic application to sporadic ALS.
  • The first poster showcases data that confirm the novel cardiotropic AAV capsid's safety and therapeutic efficacy in an animal model of cardiac dysfunction with a potential therapeutic application in genetic cardiomyopathies.

KNOWESIS AWARDED KEY CONTINUATION OF WORK AT THE DEFENSE HEALTH AGENCY RESEARCH AND ENGINEERING (R&E) DIRECTORATE PERFORMING RESEARCH PORTFOLIO MANAGEMENT SUPPORT SERVICES

Retrieved on: 
Tuesday, March 12, 2024

FAIRFAX, Va., March 12, 2024 /PRNewswire/ -- Knowesis, Inc. (hereafter Knowesis) was awarded the Research Portfolio Management Support Services Task Order in support of the Defense Health Agency (DHA).

Key Points: 
  • FAIRFAX, Va., March 12, 2024 /PRNewswire/ -- Knowesis, Inc. (hereafter Knowesis) was awarded the Research Portfolio Management Support Services Task Order in support of the Defense Health Agency (DHA).
  • This task order was competitively awarded through the OMNIBUS IV vehicle within Market Segment 4.
  • This is a continuation of ongoing support to the DHA's Research and Engineering (R&E) Directorate, Science and Technology Enterprise Integration Division to continually improve portfolio management, programmatic support, and strategic planning for the Science and Technology Defense Health Program portfolio.
  • We currently support multiple entities within the Departments of Defense, Veterans Affairs, Homeland Security, and Health and Human Services.

H2O.ai Launches GenAI World in Atlanta to Bring Education and Awareness of Responsible AI and Guardrails for Safety, Fairness and Privacy for Generative AI in Banking

Retrieved on: 
Monday, January 22, 2024

H2O.ai, the open source leader in Generative AI and machine learning, continues its world tour of bringing GenAI Training Days to major cities around the world to further democratize GenAI.

Key Points: 
  • H2O.ai, the open source leader in Generative AI and machine learning, continues its world tour of bringing GenAI Training Days to major cities around the world to further democratize GenAI.
  • Join David Palmer , Neil Desai , and Loren Bushkar as they explore the ethical, practical, and regulatory aspects of AI throughout the finance sector and more.
  • Join H2O.ai Makers to learn about Responsible AI and Guardrails for Safety, Fairness, and Privacy in Generative AI for banking.
  • Founded in 2012, H2O.ai is at the forefront of the AI movement to democratize Generative AI.

CDISC is Proud to Announce a Research Collaboration to Incorporate FDA Business Rules into CDISC’s Open Rules Engine (CORE)

Retrieved on: 
Tuesday, January 16, 2024

CDISC is proud to announce a research collaboration with the U.S. Food and Drug Administration’s Office of Translational Sciences in the Center for Drug Evaluation and Research and Office of Regulatory Operations in the Center for Biologics Evaluation and Research to incorporate FDA Business Rules into CDISC’s Open Rules Engine (CORE).

Key Points: 
  • CDISC is proud to announce a research collaboration with the U.S. Food and Drug Administration’s Office of Translational Sciences in the Center for Drug Evaluation and Research and Office of Regulatory Operations in the Center for Biologics Evaluation and Research to incorporate FDA Business Rules into CDISC’s Open Rules Engine (CORE).
  • CDISC’s CORE project provides an open-source version of the CDISC Conformance Rules in a machine-executable format.
  • These rules, published and managed by CDISC, create a single source for conformance rules and allow external vendors and sponsor companies to implement and extend these rules within their tools.
  • FDA Business Rules are currently written in a plain text, non-machine executable format and describe the business requirements for regulatory review to help ensure that clinical trial study data is compliant and useful and supports meaningful review and analysis.

RIKEN Selects Quantinuum System Model H1 for Large-Scale Hybrid Quantum-Supercomputing Platform in Japan

Retrieved on: 
Wednesday, January 10, 2024

BROOMFIELD, Colo. and LONDON, Jan. 9, 2024 /PRNewswire/ -- Quantinuum, the world's largest integrated quantum computing company, and RIKEN, Japan's largest comprehensive research institution and home to a world-leading high-performance computing (HPC) center, have announced an agreement in which Quantinuum will provide access to Quantinuum's highest performing H1-Series ion-trap quantum computing technology to RIKEN. Under the agreement, Quantinuum will install the hardware at RIKEN's campus in Wako, Saitama.

Key Points: 
  • Under the agreement, Quantinuum will install the hardware at RIKEN's campus in Wako, Saitama.
  • The deployment will be part of RIKEN's project to build a quantum-HPC hybrid platform consisting of high-performance computing systems, such as the supercomputer Fugaku and quantum computers.
  • As the project goal, RIKEN and its collaborators aim to demonstrate the advantages of such hybrid computational platforms for deployment as services in the future post-5G era.
  • "We are honored to be selected to be part of this ambitious, advanced project in Japan," said Dr. Rajeeb Hazra, CEO of Quantinuum.

RIKEN Selects Quantinuum System Model H1 for Large-Scale Hybrid Quantum-Supercomputing Platform in Japan

Retrieved on: 
Wednesday, January 10, 2024

BROOMFIELD, Colo. and LONDON, Jan. 10, 2024 /PRNewswire/ -- Quantinuum, the world's largest integrated quantum computing company, and RIKEN, Japan's largest comprehensive research institution and home to a world-leading high-performance computing (HPC) center, have announced an agreement in which Quantinuum will provide access to Quantinuum's highest performing H1-Series ion-trap quantum computing technology to RIKEN. Under the agreement, Quantinuum will install the hardware at RIKEN's campus in Wako, Saitama.

Key Points: 
  • Under the agreement, Quantinuum will install the hardware at RIKEN's campus in Wako, Saitama.
  • The deployment will be part of RIKEN's project to build a quantum-HPC hybrid platform consisting of high-performance computing systems, such as the supercomputer Fugaku and quantum computers.
  • As the project goal, RIKEN and its collaborators aim to demonstrate the advantages of such hybrid computational platforms for deployment as services in the future post-5G era.
  • "We are honored to be selected to be part of this ambitious, advanced project in Japan," said Dr. Rajeeb Hazra, CEO of Quantinuum.

VAST Data Simplifies and Secures Hybrid Cloud Data Management While Delivering up to 80 Percent Cost Savings on AWS Cloud

Retrieved on: 
Wednesday, November 29, 2023

With the VAST Data Platform, organizations benefit from enterprise data management capabilities and infrastructure efficiencies to easily manage files, objects, and tables wherever computation happens.

Key Points: 
  • With the VAST Data Platform, organizations benefit from enterprise data management capabilities and infrastructure efficiencies to easily manage files, objects, and tables wherever computation happens.
  • Additionally, cloud-native organizations can now start their journey with VAST in the cloud to gain access to the transformative capabilities of the VAST Data Platform.
  • “The VAST Data Platform makes it simple for the Allen Institute to rapidly share and process data anywhere.
  • “The VAST Data Platform is the simplest, fastest, most efficient and most secure way for customers to achieve AI-powered insights from all of their data, across private and public clouds,” said Jeff Denworth, Co-Founder of VAST Data.

Code Ocean Partners with the Allen Institute to Accelerate Neuroscience

Retrieved on: 
Wednesday, November 15, 2023

NEW YORK, Nov. 15, 2023 /PRNewswire-PRWeb/ -- Code Ocean, the world's first Reproducible Research Cloud, today announced its ongoing partnership with the Allen Institute, based on a shared commitment to scientific discovery and open collaboration. Less than a year into their partnership, the Allen Institute has achieved a 4x increase in workflow efficiency, in addition to recognizing many other benefits of increased reproducibility, interoperability and collaboration.

Key Points: 
  • "Our partnership with Allen Institute has helped us to refine our ability to accommodate the specialized needs of large organizations," said Dr. Daniel Koster, Director of Product at Code Ocean.
  • The Allen Institute is a Seattle-based independent nonprofit bioscience and medical research institute founded by Microsoft co-founder and philanthropist Paul G. Allen.
  • Since implementing Code Ocean, the Allen Institute has seen a dramatic increase in interoperability and productivity.
  • Code Ocean has developed a wide range of dedicated features to assist large organizations such as the Allen Institute to operate effectively at scale.

Code Ocean Introduces New Offering for Academic Research Labs

Retrieved on: 
Wednesday, October 18, 2023

NEW YORK, Oct. 18, 2023 /PRNewswire-PRWeb/ -- Code Ocean, the world's first Reproducible Research Cloud, today introduced a new academic offering, exclusively available to university research labs. With deeper support and more robust capabilities, the new Code Ocean Academic Lab Offering includes the ability to not only publish, but also to build upon work that has been previously published by other institutions and teams.

Key Points: 
  • NEW YORK, Oct. 18, 2023 /PRNewswire-PRWeb/ -- Code Ocean , the world's first Reproducible Research Cloud, today introduced a new academic offering, exclusively available to university research labs.
  • "Code Ocean is now making many of the features that were previously associated only with our enterprise platform available to university academic labs free of charge, in order to support better collaboration within the research sector," said Simon Adar, Co-founder and CEO, Code Ocean.
  • With its new academic offering, Code Ocean is extending its support for academia beyond its existing Open Science Library by providing the very first complete system of record for reproducible science to the academic community.
  • The Code Ocean Academic offering is free of charge for academic labs to self-install and maintain with available online documentation.